Julie Randolph-Habecker PhD
Dr. Randolph-Habecker received her Master’s in Clinical Chemistry in 1993 and PhD in Pathology in 1998 from The Ohio State University. Her research focus in Cytomegalovirus led her to a postdoctoral fellowship at Fred Hutchinson Cancer Research Center in Seattle Washington. In 2003, Dr. Randolph-Habecker was appointed as the Director of Experimental Histopathology at Fred Hutch where she did collaborative research in areas including cancer, infectious disease, chronic illness, and basic research. She has leveraged her extensive knowledge of translational research, biomarker discovery, companion diagnostic development, and digital pathology to consult with other academic institutions and biotechnology and pathology diagnostic companies.
Dr. Randolph-Habecker also helped plan and implement a histopathology laboratory in Kampala, Uganda as part of the Fred Hutch/Uganda Cancer Institute clinic. She is a member of the Pathology Improvement Committee for the Burkitt’s Lymphoma Fund for Africa and the president and co-founder of One World Histopathology, a non-profit whose mission is to improve access to pathology diagnostic in low resource and underserved communities. Dr. Randolph-Habecker is a member of the American Society for Investigative Pathology (ASIP), the Histochemical Society (HCS), and the National Society for Histotechnology (NSH).